Navigation Links
Study indicates pregnancy does not harm chances of survival from cancer
Date:9/27/2007

Barcelona, Spain: New research offers reassurance to women worried about whether getting pregnant after cancer treatment might worsen their prognosis.

The study by Norwegian scientists, presented today (Thursday) at the European Cancer Conference (ECCO 14) in Barcelona, found that for almost all types of cancer, the survival of women who are diagnosed during pregnancy or who became pregnant after being treated for the disease is no different from that of other female cancer patients.

The only exception was for breast cancer diagnosed during lactation, where women were 1.9 times more likely than normal to die from their cancer, said Dr Hanne Stensheim, a research fellow at the Norwegian Cancer Registry in Oslo, Norway, who led the study. We think this is mainly based on greater delay in diagnosis, rather than any influence of the lactation process itself. It may be more difficult to diagnose breast cancer during lactation because many women get lumps due to mastitis and because normal physiological changes in the breast might mask suspicious developments.

Breast cancer is one of the most common cancers diagnosed during pregnancy, but pregnancy-related breast cancer is relatively rare. Studies have suggested that between 0.2 percent and 3.8 percent of breast cancers diagnosed in women under age 50 are detected during pregnancy or the postpartum period.

In the study, the scientists tracked the cancer of 45,511 women for an average of eight years and compared the survival rates of patients who did not get pregnant with those of patients who either were diagnosed during the gestation or lactation period, or who got pregnant after cancer diagnosis and treatment.

Many women are concerned about pregnancy after cancer, as are many doctors. There have been several hypotheses for decades proposing that complex hormonal changes and immunologic alterations associated with pregnancy might promote cancer growth, Stensheim said. Those studies that confirm such hypotheses are often based on small numbers and the findings could be due to selection bias. I see our results as further reassurance that pregnancy factors are not influencing the cancer development per se.

While previous studies on cancer during pregnancy tended to investigate a single cancer type and draw information from a single institution, the latest study is population-based and includes all cancer types found in Norwegian women diagnosed between 1967 and 2004 and is thus among the broadest studies of its type to date.

With adjustments for age, stage and diagnostic period, we found no significant difference in survival for pregnant women diagnosed with a malignancy compared to non-pregnant cancer-patients, Stensheim said. I think this might justify the statement that pregnancy does not affect the clinical final outcome of a malignant disease in general.


'/>"/>

Contact: Emma Ross
rosswrite@mac.com
34-932-308-832
ECCO-the European CanCer Conference
Source:Eurekalert

Related medicine news :

1. Rural Canadians travel far for specialists: study
2. A new study surpasses Gene Therapy Hurdle
3. Tomato Sauce reduces Cancer Risk- Study
4. A question on study of Adult Stem Cell
5. Study on obesity and heart failure
6. National Lung Study in the process
7. Marijuana gateway theory strengthened by study of twins
8. Old theory of adaptation confirmed by new study
9. Study casts doubt on keyboard ills
10. Gene study links endometriosis, infertility
11. Study reveals how stress can make you sick
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... ... December 07, 2016 , ... The Cliff Hart ... in South Lyon, Dewitt, Williamston, East Lansing, Ann Arbor, and Farmington Hills, is ... for a brain tumor. , Jason Bauer and his family are longtime members ...
(Date:12/7/2016)... ... , ... A. Kevin Spann Insurance, a New York-based firm offering insurance and ... a charity drive to raise funds that will benefit the Marine Corps League. , ... Navy FMF Corpsmen. Working closely with the MCL, the A. Kevin Spann team plans ...
(Date:12/7/2016)... ... December 07, 2016 , ... Delete® - Tattoo Removal and ... The Holiday Party Season. Save Up To 33% Off Botox® and Juvederm® Products Now ... the Phoenix Valley with Delightful Deals on Botox® and Juvederm® just in ...
(Date:12/7/2016)... CINCINNATI, Ohio (PRWEB) , ... December 07, 2016 ... ... winner in the 2016 BOC Business Brilliance Awards under the Best New Product ... inception and results achieved through user experience. , BOC Global Events & Training ...
(Date:12/7/2016)... , ... December 07, 2016 , ... “Walking With God: ... stories that will inspire the reader to be aware of God's direction in their ... published author, Sanford Smith, retired teacher and active church leader. , Sanford ...
Breaking Medicine News(10 mins):
(Date:12/7/2016)... NESS ZIONA SCIENCE PARK , ... Israeli biotechnology company Kadimastem (TASE: KDST) announced today the signing of ... strategic collaboration between the companies. The synergy between the companies will ... Kadimastem-Corestem collaboration as a worldwide leader in innovative treatment for severe ... ...
(Date:12/7/2016)... December 7, 2016 According to a new market ... Mode, Product Type (Integrated, Standalone), Model (Knowledge-Based), Type (Therapeutic, Diagnostic), User Interactivity ... Market is expected to reach USD 1,519.2 Million by 2021 from USD ... Continue Reading ... ...
(Date:12/7/2016)... LONDON , Dec. 7,2016  Based ... drug delivery industry, Frost & Sullivan recognizes ... Frost & Sullivan Award for Enabling Technology ... plug the loopholes in traditional drug delivery ... and liquid microneedle-based drug delivery technologies, Memspatch ...
Breaking Medicine Technology: